Christopher Gallagher

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 302 citations · Full text

Medicine, Oncology, Breast Oncology +16

Phase III Randomized Trial of Doxorubicin and Docetaxel Versus Doxorubicin and Cyclophosphamide As Primary Medical Therapy in Women With Breast Cancer: An Anglo-Celtic Cooperative Oncology Group Study

T.R. Jeffry Evans, Ann Yellowlees, E. Foster et al. · Journal of Clinical Oncology · 2005 · 174 citations

Medicine, Oncology, Pharmacotherapy +14

Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype

Brenda Deyarmin, Jennifer Kane, Allyson L. Valente et al. · Annals of Surgical Oncology · 2012 · 151 citations

Medicine, Molecular Biology, Pathology +6

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

Filipa Lynce, Ana Barac, Xue Geng et al. · Breast Cancer Research and Treatment · 2019 · 145 citations · Full text

Medicine, Cardiology, Oncology +17

Reduction of the MAC of Desflurane with Fentanyl

Peter S. Sebel, Peter S. A. Glass, James E. Fletcher et al. · Anesthesiology · 1992 · 130 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13